We stand by always ready to provide
optimal strategies for your company
scroll
Takanori ABE's article titled "Analysing the first generic drug cartel case" had been published on Managing Intellectual Property Magazine(July/August 2019).
Takanori ABE published the article titled "Analyzing the first generic drug cartel case".
Takanori ABE will give a lecture entitled "Pay for Delay" at 2019 AIPPI World Congress Pharma Session 1- Wait! Pay for Delay.
Nichia Corporation v. Everlight Electronics
U.S. Patent Infringement Lawsuit
Takanori ABE's article titled "Takanori Abe reviews the litigation in Germany over Nichia's patent for a white LED" was cited in PETITION FOR WRIT OF CERTIORARI Nichia Corporation submitted to the U.S. Supreme Court.
Biopharmaceutical Company v. Pharmaceutical Company
AAA Arbitration
Takanori ABE has submitted an expert opinion and testified at the deposition.
Shire v. Japanese Pharmaceutical Company
ABE & PARTNERS represented Shire in M&A Due Diligence.
Baxalta v. Chugai
Patent Infringement Lawsuit
Mitsubishi Tanabe Pharma v. Nissin Pharmaceutical
Patent Infringement Lawsuit
Resolved by Settlement
"Abe & Partners makes two promotions"
"New ruling on scope of extended patent right"
"Patent Practice to win the competition"
"Special Report, Courageous Challenge from Solo Practice to General Law Firm"（Interview with Takanori ABE)
"Intellectual Property License Agreement - Theory and Practice"
＜Caution＞
ABE & PARTNERS has received information that the name of our firm and atrorney
from our office have been used to attempt to commit fraud.
If you receive any contact from an unknown person using the name of our office or an attorney from our office, do not respond immediately, but please fully confirm the identity of that person.
In addition, we would greatly appreciate your informing us by using "Contact".